Senseonics Holdings (SENS) Stock Price, Quote & News

Company Profile

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time d...

Industry: Medical Devices

Sector: Healthcare

Phone: 301 515 7260

Fax: 833 552 7007

Website: www.senseonics.com

Address:

20451 Seneca Meadows Parkway, Germantown, United States

LeMatt Aug. 24 at 12:22 PM

$SENS The needle didn’t move too much in the last few weeks… but it could only take a few months to go from 10 to 100. With that being said, in October we could already be around $60. Holding well on the roller coaster ;)

0 · Reply

PattyPooner Aug. 24 at 9:45 AM

$SENS not trying to claim same type run is about to happen, but if it were to continue with strength and go much higher, comparing to nov 2020 run, it took 3 months to climb from ATL up, proceeded to drop over the next 3 months, climbed another month, fell another month, and peaked a month after that. We’ve now had 2 strong weeks of upward momentum, dont be surprised if it cools a bit here and stays rangebound between 8-11.

0 · Reply

Waterman148 Aug. 24 at 3:26 AM

$SENS I remember reading if this thing broke 958 we would break 1140 so when’s that supposed to happen lol

0 · Reply

Learningtoretire Aug. 24 at 1:21 AM

$SENS any gas left in this thing

0 · Reply

MVISMEME Aug. 23 at 7:50 PM

$MVIS $MVIS longs modeling recovery should study $SENS first. Same vintage (1996), same structure: pre-profit sensor co, converts + ATM, reverse split, loyal retail, "partner ramp next quarter." Difference: SENS got the thing MVIS is waiting for — FDA product, real growing revenue, global partner. Result: −55% in 3yrs, −83% peak-to-trough, a 4x rally fully retraced. Alive, diluting, going nowhere. Lesson: revenue existing ≠ saved. Revenue > burn is the bar. For MVIS that's ~$60M/yr against ~$6M today. Watch Nov 10-Q for scale math, not just "a ramp." Three paths exist: recovery (OUST AEVA), spiral (LIDR INVZ), zombie (SENS). The filings pick the path, not the tape.

4 · Reply

R3JS Aug. 23 at 7:28 PM

$MVIS crazy I have 30,000 shares pre split 🤯 I love reverse splits before mooning!! You want to see the future just look at $SENS and what happened after reverse split the white line is the quarter of reverse split and now there is a buy signal that will moon it. Just like MVIS is was labeled a “stonk” its stonk season and I don’t like the label they gave my favs but it’s time.

1 · Reply

USAEquityResearch Aug. 23 at 11:03 AM

$SENS 📊 USAEquityResearch ▲ 9.71 (+10.09%) Trend: Bullish 📈 RSI (14): 87.6 — overbought, extended, caution warranted MACD: bullish, above signal line and rising Volume: above average 📌 Key Levels Resistance: 9.71 | Support: 4.87 20-MA: 6.81 | 50-MA: 6.15 💼 Fundamentals Mkt Cap: $513.41M FCF: $-59.24M (-1.12/sh) Total Debt: $62.82M D/E: 69.56 📉 Options (exp 2026-09-18) ATM IV: 64.3% | Skew: +24.8% (put-heavy) P/C Ratio: 0.67 🐂 Bullish lean Max Pain: 7.50 Call wall: 10.00 | Put wall: 7.50 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/SENS

0 · Reply

DiamondDelta Aug. 23 at 3:06 AM

$SENS $QNCX My top choice for next big runner is OLOX. OLOX -Bitcoin miner+AI fit the theme, makes the most sense. $11 book value, 20 RSI on the daily 96 short squeeze score. Just the bounce in itself could be 200-300%. OLOX put it on ur watch!!

0 · Reply

londoneast Aug. 22 at 5:56 PM

$SENS I continue to believe that SENS represents a compelling strategic acquisition opportunity for one of the major players in the diabetes or medical technology sector. A potential transaction could well involve a combination of cash and shares, and I would be entirely comfortable retaining an equity interest in a larger, well-capitalised medical device or pharmaceutical company. Given the value and long-term potential of the Eversense technology platform, I believe a strategic acquisition remains a very plausible outcome.

1 · Reply

Udbsbzis Aug. 22 at 3:46 PM

$SENS 24.51 to break even .🤣🤣🤣 Jesus I’m a fool

2 · Reply

Senseonics reports Q2 EPS (63c), consensus (62c)

Aug 6, 2026, 4:30 PM EDT - 17 days ago

Senseonics Holdings Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 17 days ago

Senseonics Holdings Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 17 days ago

Senseonics Holdings Quarterly report: Q2 2026

Jul 21, 2026, 8:00 AM EDT - 4 weeks ago

Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time

2026-07-15T11:31:55.000Z - 5 weeks ago

Senseonics price target lowered to $18 from $20 at Mizuho

2026-06-07T22:35:54.000Z - 2 months ago

Senseonics announces further data from study of Eversense 365

Jun 6, 2026, 8:00 AM EDT - 2 months ago

Senseonics Holdings Transcript: Investor update

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026

May 20, 2026, 10:00 AM EDT - 3 months ago

Senseonics Holdings Transcript: AGM 2026

2026-05-12T10:17:11.000Z - 3 months ago

Senseonics price target lowered to $14 from $18.50 at H.C. Wainwright

2026-05-11T11:48:30.000Z - 3 months ago

Senseonics price target lowered to $8 from $9 at Stifel

2026-05-08T16:19:10.000Z - 3 months ago

Senseonics price target lowered to $12 from $20 at Lake Street

2026-05-07T21:38:40.000Z - 3 months ago

Senseonics reports Q1 EPS (71c), consensus (70c)

May 7, 2026, 4:30 PM EDT - 3 months ago

Senseonics Holdings Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Senseonics Holdings Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Senseonics Holdings Quarterly report: Q1 2026

May 7, 2026, 4:01 PM EDT - 3 months ago

Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results

May 4, 2026, 4:01 PM EDT - 3 months ago

Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

May 4, 2026, 8:00 AM EDT - 4 months ago

Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million

HTGC

May 1, 2026, 9:10 AM EDT - 4 months ago

Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time

Apr 30, 2026, 9:50 PM EDT - 4 months ago

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

2026-04-30T20:07:00.000Z - 4 months ago

Senseonics announces common stock offering, no amount given

Apr 30, 2026, 4:01 PM EDT - 4 months ago

Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

Apr 24, 2026, 7:00 AM EDT - 4 months ago

Senseonics Announces European Launch of Eversense® 365, The World's First and Only One Year CGM System

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Senseonics Holdings Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Senseonics Holdings Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 5 months ago

Senseonics Holdings Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 5 months ago

Senseonics Holdings Proxy statement: Proxy filing

Mar 14, 2026, 10:15 AM EDT - 5 months ago

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Mar 2, 2026, 4:30 PM EST - 6 months ago

Senseonics Holdings Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Senseonics Holdings Annual report: Q4 2025

Mar 2, 2026, 4:30 PM EST - 6 months ago

Senseonics Holdings Earnings release: Q4 2025

2026-03-02T21:15:11.000Z - 6 months ago

Senseonics reports Q4 EPS (46c), consensus (43c)

2026-03-02T21:14:02.000Z - 6 months ago

Senseonics sees FY26 revenue $58M-$62M, consensus $60.38M

Mar 2, 2026, 4:01 PM EST - 6 months ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

2026-02-19T13:10:00.000Z - 6 months ago

Senseonics, Sequel Med Tech launch twiist integrated with Eversense 365

Feb 19, 2026, 8:00 AM EST - 6 months ago

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

Feb 19, 2026, 8:00 AM EST - 6 months ago

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365

2026-01-29T21:37:18.000Z - 7 months ago

Senseonics announces CE Mark approval for Eversense 365 CGM system

Jan 29, 2026, 4:01 PM EST - 7 months ago

Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Jan 8, 2026, 4:01 PM EST - 8 months ago

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System

Nov 12, 2025, 4:40 PM EST - 10 months ago

Senseonics Holdings Transcript: Stifel 2025 Healthcare Conference

Nov 9, 2025, 6:00 PM EST - 10 months ago

Senseonics Holdings Slides: Corporate Presentation

Nov 5, 2025, 4:30 PM EST - 10 months ago

Senseonics Holdings Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Senseonics Holdings Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

Senseonics Holdings Earnings release: Q3 2025

Oct 22, 2025, 4:05 PM EDT - 10 months ago

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

Oct 6, 2025, 4:05 PM EDT - 11 months ago

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Transcript: Status Update

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Press release: Status Update

Sep 3, 2025, 7:22 PM EDT - 1 year ago

Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics

Sep 3, 2025, 5:17 PM EDT - 1 year ago

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Aug 18, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings release: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Reports Second Quarter Financial Results

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Registration statement: Registration Filing

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Jul 16, 2025, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

Jun 4, 2025, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

May 21, 2025, 5:06 PM EDT - 1 year ago

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

May 15, 2025, 11:12 PM EDT - 1 year ago

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 15, 2025, 4:05 PM EDT - 1 year ago

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

May 8, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Senseonics Holdings Earnings release: Q1 2025

Apr 29, 2025, 4:05 PM EDT - 1 year ago

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

Apr 29, 2025, 7:30 AM EDT - 1 year ago

Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Mar 4, 2025, 3:10 PM EST - 1 year ago

Senseonics Holdings Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Senseonics Holdings Annual report: Q4 2024

Mar 3, 2025, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings release: Q4 2024

Mar 3, 2025, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 26, 2025, 7:30 AM EST - 1 year ago

Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care

Feb 13, 2025, 4:05 PM EST - 1 year ago

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 6, 2025, 4:05 PM EST - 1 year ago

Senseonics Completes CE Mark Submission for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

Jan 8, 2025, 6:12 PM EST - 1 year ago

Senseonics Holdings, Inc. Announces Business Updates Including Preliminary 2024 Results, 365 Launch Update and Cancellation of Special Meeting

Dec 9, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Nov 29, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Nov 27, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Registration statement: Registration Filing

Nov 19, 2024, 9:10 AM EST - 1 year ago

Senseonics Holdings Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 7:00 AM EST - 1 year ago

Senseonics Holdings Proxy statement: Proxy Filing

Nov 7, 2024, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Senseonics Holdings Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Senseonics Holdings Earnings release: Q3 2024

Oct 16, 2024, 4:30 PM EDT - 2 years ago

Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

Oct 10, 2024, 4:10 PM EDT - 2 years ago

Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor

Oct 1, 2024, 11:00 AM EDT - 2 years ago

Eversense 365 Launches in the US: One Year. One CGM.

Sep 17, 2024, 7:00 AM EDT - 2 years ago

Eversense 365 Receives FDA Clearance: The World's First One Year CGM

Sep 6, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings release: Q2 2024

Aug 8, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results

Jul 25, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern Time

Jun 21, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial Outlook

Jun 13, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific Sessions

Jun 12, 2024, 1:45 PM EDT - 2 years ago

Senseonics Holdings Transcript: Small-Cap Growth Virtual Investor Conference

May 29, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference

May 20, 2024, 4:00 PM EDT - 2 years ago

Senseonics Holdings Transcript: H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 15, 2024, 3:35 PM EDT - 2 years ago

Senseonics Holdings Transcript: RBC Capital Markets 2024 Global Healthcare Conference

May 15, 2024, 3:35 PM EDT - 2 years ago

Senseonics Holdings Slides: FY 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Quarterly report: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

Senseonics Holdings Earnings release: Q1 2024

May 13, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results

May 13, 2024, 4:04 PM EDT - 2 years ago

Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management

May 9, 2024, 4:05 PM EDT - 2 years ago

Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution

May 2, 2024, 8:05 AM EDT - 2 years ago

Senseonics Holdings, Inc. to Participate in Upcoming Conferences

Apr 30, 2024, 4:05 PM EDT - 2 years ago

Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern Time

Apr 30, 2024, 7:00 AM EDT - 2 years ago

Eversense® CGM System Receives iCGM Designation by the US FDA

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Senseonics Holdings Proxy statement: Proxy Filing

Apr 12, 2024, 8:00 AM EDT - 2 years ago

Senseonics Holdings Proxy statement: Proxy Filing

Apr 2, 2024, 8:00 AM EDT - 2 years ago

Senseonics Holdings Proxy statement: Proxy Filing

Mar 13, 2024, 12:00 PM EDT - 2 years ago

Senseonics Holdings Transcript: Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Mar 12, 2024, 7:00 AM EDT - 2 years ago

SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS

Mar 8, 2024, 8:05 AM EST - 2 years ago

Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes

LeMatt Aug. 24 at 12:22 PM

0 · Reply

PattyPooner Aug. 24 at 9:45 AM

0 · Reply

Waterman148 Aug. 24 at 3:26 AM

$SENS I remember reading if this thing broke 958 we would break 1140 so when’s that supposed to happen lol

0 · Reply

Learningtoretire Aug. 24 at 1:21 AM

$SENS any gas left in this thing

0 · Reply

MVISMEME Aug. 23 at 7:50 PM

4 · Reply

R3JS Aug. 23 at 7:28 PM

1 · Reply

USAEquityResearch Aug. 23 at 11:03 AM

0 · Reply

DiamondDelta Aug. 23 at 3:06 AM

0 · Reply

londoneast Aug. 22 at 5:56 PM

1 · Reply

Udbsbzis Aug. 22 at 3:46 PM

$SENS 24.51 to break even .🤣🤣🤣 Jesus I’m a fool

2 · Reply

LudwigVanBeethoven Aug. 22 at 3:08 PM

$SENS I have to admit, I missed the last leg :) Bravo!

1 · Reply

Thi20 Aug. 21 at 10:54 PM

$SENS Sessa Capital’s financial portfolio is valued at over $5.7 billion. More than 25% of its total capital is invested in a single company—Humana—with a value of approximately $1.5 billion. Why is this significant? Humana is no ordinary company; it is the undisputed leader in Medicare Advantage contracts (the system through which the government outsources the management of public Medicare coverage to private insurers). The source of influence: As Humana’s largest shareholder, Sessa Capital holds significant sway within the insurer’s Board of Directors. They maintain direct contact with the executives who negotiate daily with federal health authorities in Washington to determine the list of reimbursable medical devices.

0 · Reply

Form4Alerts Aug. 21 at 10:44 PM

$SENS The last time this insider purchased this stock, it was up 39% over the next 90 days. Wouldn't be surprised to see similar price action this time around.

0 · Reply

aristocks Aug. 21 at 10:38 PM

$SENS don’t get me wrong… I am happy about the price movement in this for the past month.. I have been holding the bag for few years now… I am just questioning the substance of this ran up.. Anyone has some insights on how the upside beside a slight best and raise? Thanks 🙏

1 · Reply

chase1532 Aug. 21 at 9:08 PM

$SENS I still divide everything by 20, so I'm not impressed quite yet

5 · Reply

crabbypatty31 Aug. 21 at 8:33 PM

$SENS Are ya kiddin' me??? Most encouraging price action in eons!! Lovin' it!!😍

0 · Reply

LupusLeoqueGlobalPartnrs Aug. 21 at 8:22 PM

$SENS Dear Timmy, We would like to buy back in, sub $6 this time, before we become profitable. Please offer us a dilution, we will make sure to save some funds to the side. Only bearish because we’re poor and want cheap shares. Thank you!

0 · Reply

alderson95 Aug. 21 at 8:21 PM

$SENS

0 · Reply

pathfinder63 Aug. 21 at 7:41 PM

$SENS hitting 10$ today will be a very strong statement for next week

0 · Reply

dlp02446 Aug. 21 at 7:24 PM

$SENS We might get a little surprise here at the end. I think a lot of shorts are skittish this weekend. I know I would be. Let's see what this 30 minutes bring!

0 · Reply

JInvestTrade Aug. 21 at 7:02 PM

$SENS https://lnkd.in/p/ghYxgxuS

0 · Reply

PattyPooner Aug. 21 at 6:48 PM

$SENS big pop next week is my guess, would be nice to see a strong power hour above 10 to end the week but doesn’t seem likely

0 · Reply

Market Cap	342.17M
Revenue (ttm)	22.47M
Net Income (ttm)	-78.62M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-349.89%
Debt to Equity Ratio	0.37

Volume	6,378,656
Avg Vol	7,343,204
Day's Range	N/A - N/A
Shares Out	814.68M
Stochastic %K	20%
Beta	0.83
Analysts	Sell
Price Target	$1.43